{"title":"单克隆抗体治疗慢性淋巴细胞白血病","authors":"Clive S. Zent","doi":"10.1016/j.onsig.2018.09.002","DOIUrl":null,"url":null,"abstract":"<div><p>Optimal use of therapeutic monoclonal antibodies therapy requires an understanding of their mechanisms of action and how CLL cells resist these cytotoxic effects. This critical review details current knowledge and questions.</p></div>","PeriodicalId":92564,"journal":{"name":"Oncology signaling","volume":"1 1","pages":"Pages 11-13"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.onsig.2018.09.002","citationCount":"0","resultStr":"{\"title\":\"Monoclonal antibody therapy in chronic lymphocytic leukemia\",\"authors\":\"Clive S. Zent\",\"doi\":\"10.1016/j.onsig.2018.09.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Optimal use of therapeutic monoclonal antibodies therapy requires an understanding of their mechanisms of action and how CLL cells resist these cytotoxic effects. This critical review details current knowledge and questions.</p></div>\",\"PeriodicalId\":92564,\"journal\":{\"name\":\"Oncology signaling\",\"volume\":\"1 1\",\"pages\":\"Pages 11-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.onsig.2018.09.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology signaling\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S254256331830024X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology signaling","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S254256331830024X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Monoclonal antibody therapy in chronic lymphocytic leukemia
Optimal use of therapeutic monoclonal antibodies therapy requires an understanding of their mechanisms of action and how CLL cells resist these cytotoxic effects. This critical review details current knowledge and questions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
